<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Financial Analysis on FinanClub</title>
    <link>https://finan.club/tags/financial-analysis/</link>
    <description>Recent content in Financial Analysis on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 10 Jan 2024 09:03:07 +0000</lastBuildDate><atom:link href="https://finan.club/tags/financial-analysis/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Wed, 10 Jan 2024 09:03:07 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:343
Chances: TG Therapeutics, Inc. has entered into an agreement to acquire a worldwide license to Precision BioSciences, Inc.&amp;rsquo;s Azercabtagene Zapreleucel (azer-cel), an allogeneic CD19 CAR T cell therapy program for autoimmune diseases. The average of price targets set by Wall Street analysts indicates a potential upside of 127.</description>
    </item>
    
    <item>
      <title>KSS</title>
      <link>https://finan.club/us/kss/</link>
      <pubDate>Tue, 12 Dec 2023 14:03:29 +0000</pubDate>
      
      <guid>https://finan.club/us/kss/</guid>
      <description>score:20
Chances: Kohl&amp;rsquo;s shares jumped 7.3% in solidarity with Macy&amp;rsquo;s after an investor group made a $5.8 billion offer to take Macy&amp;rsquo;s private Risks: The retail industry is facing challenges such as stiff competition from online rivals and high inflation Score:20 chances characters count - risks characters count = -980</description>
    </item>
    
  </channel>
</rss>
